In this study, the use of intravenous maintenance fluid with 35 mmol/L of sodium was significantly associated with an increased risk of hyponatremia compared to that with 140 mmol/L of sodium in adult postoperative critically ill patients.
Background
The choice of postoperative intravenous fluid is important [1] . The use of a sodium-poor fluid, called hypotonic fluid [2, 3] , continues to be recommended as intravenous maintenance fluid for acutely ill adult patients [4, 5] . However, several studies, mainly in pediatric patients, have suggested that the use of such a hypotonic fluid is associated with an increased risk of the development of hyponatremia [2, [6] [7] [8] . Hyponatremia is known to be associated with poor outcomes and, thus, should be avoided [9, 10] . Therefore, it is still unclear whether hypotonic fluid should be used in patients postoperatively [3] .
In the study site, sodium-poor fluid (35 mmol/L of sodium: Na 35 ) was routinely used as intravenous maintenance fluid for postoperative critically ill patients until the end of July 2015. Because of the above concern, it was decided to use isotonic fluid (140 mmol/L of sodium: Na 140 ) as intravenous maintenance fluid from August 2015. Accordingly, we compared these two periods to determine the effect of sodium concentration in the postoperative intravenous maintenance fluid on the incidence of hyponatremia in adult postoperative critically ill patients.
Abstract
Purpose The purpose of this study was to compare the incidences of hyponatremia in adult postoperative critically ill patients receiving isotonic and hypotonic maintenance fluids. Methods In this single-center retrospective before/after observational study, we included patients who had undergone an elective operation for esophageal cancer or for head and neck cancer and who received postoperative intensive care for >48 h from August 2014 to July 2016. In those patients, sodium-poor solution (35 mmol/L of sodium; Na 35 ) had been administered as maintenance fluid until July 2015. From August 2015, the protocol for postoperative maintenance fluid was revised to the use of isotonic fluid (140 mmol/L of sodium; Na 140 ). The primary outcome was the incidence of hyponatremia (<135 mmol/L) until the morning of postoperative day (POD) 2. Results We included 179 patients (Na 35 : 87 patients, Na 140 : 92 patients) in the current study. The mean volume of fluid received from ICU admission to POD 2 was not significantly different between the two groups (3291 vs 3337 mL, p = 0.84). The incidence of postoperative hyponatremia was 16.3% (15/92) in the Na 140 cohort, which was significantly lower than that of 52.9% (46/87) in the Na 35 group (odds ratio = 0.17, 95% confidence interval 0.09-0.35, p < 0.001]. The incidences of hypernatremia, defined as serum sodium concentration >145 mmol/L, were not significantly different between the two groups.
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Methods
Study design and patients
We conducted a single-center retrospective before/after study. The Kobe University Hospital Ethics Committee approved this investigation. The committee waived the need for informed consent for studies involving the use of a database. The study site is a tertiary teaching hospital and specialist referral center with 30 intensive care unit (ICU) beds.
We screened adult patients who underwent an elective operation for esophageal cancer or for head and neck cancer. Among them, we included patients who received postoperative intensive care for more than 48 h during the period from August 2014 to July 2016. We excluded patients who had abnormalities in sodium concentration at the time of admission to the ICU (serum sodium concentration <135 or >145 mmol/L). We also excluded patients with enteral feeding during the study period.
Postoperative fluid management
The study period was defined as the period from ICU admission to 6 a.m. on postoperative day (POD) 2. Patients admitted to the ICU in the period between August 1, 2014 and July 31, 2015 were administered sodium-poor solution with 35 mmol/L of sodium as postoperative maintenance fluid (Na 35 cohort) ( Table 1) . From August 1, 2015 to July 31, 2016, patients were given isotonic fluid with 140 mmol/L of sodium as maintenance fluid (Na 140 cohort) ( Table 1) . From ICU admission to the morning of POD 2, the rate of infusion of postoperative maintenance fluid was fixed at 1 mL/body weight (kg) + 20 mL)/h in both periods (Fig. 1) . In cases of hypovolemia, Ringer's solution was given in both groups. There was no protocol for correcting sodium concentration during the study period.
Patient information
Patient baseline characteristics were extracted from the hospital's electronic medical records. The following characteristics of patients in the Na 35 and Na 140 cohorts were compared: gender, age, sex, body weight, body mass index (BMI), operation category, American Society of Anesthesiology physical status (ASA-PS), operating time, serum creatinine level at ICU admission, and APACHE (acute physiology and chronic health evaluation) II score [11] . Patients were discharged from the ICU when they did not require an inotrope or mechanical ventilation. We also obtained information on transfusion, amount of fluid received, and amounts of sodium and potassium administered.
Postoperative sodium and potassium concentrations
During the study period, serum sodium, potassium, and glucose concentrations were routinely measured using an ABL800 FLEX ® (Radiometer, Copenhagen, Denmark) at ICU admission and at 6 a.m. on POD 1 and POD 2 ( Fig. 1) . Data for serum sodium, potassium, and glucose Table 1 Composition of the two maintenance fluids
Buffer ( concentrations were stored electronically and retrieved. Enteral nutrition was routinely started in the afternoon of POD 2.
Statistical analysis
The primary outcome in this study was the incidence of hyponatremia, defined as serum sodium level <135 mmol/L, obtained at least once in the morning of POD 1 or POD 2.
We also compared the incidences of hypernatremia, defined as serum sodium level >145 mmol/L, and serum sodium, potassium, and glucose concentrations at ICU admission and at 6 a.m. on POD 1 and POD 2 as secondary outcomes.
To calculate the sample size for the current study, we hypothesized that the incidence of hyponatremia in the Na 35 group would be 50% and that the use of Na 140 fluid as maintenance fluid may be associated with 25% of the absolute difference. Assuming a ratio of patients in the Na 35 and Na 140 groups of 1:1, rate of exclusion of 15%, power of 0.90, and α level of 0.05, approximately 200 participants were required. As there were approximately 100 adult patients who underwent an elective operation for esophageal cancer or for head and neck cancer and who required postoperative intensive care for more than 48 h, we conducted this study over 2 years (1 year for each period).
The results are shown as means with standard deviation or n (%). We divided the patients into a Na 35 group and a Na 140 group. We compared these two groups using the t test, chi-squared test or two-way repeated ANOVA test as appropriate. We used R to perform statistical analysis. A p value <0.05 was defined as a statistically significant difference. When the two-way repeated ANOVA test showed a statistical difference between the two groups, we further performed post hoc analysis to analyze which time points made the significant difference. For this post hoc test, a p value <0.0167 was defined as a statistically significant difference. Data were reported in accordance with the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) guidelines.
Results
Study flow
During the study period, there were 301 patients who underwent an elective operation for esophageal cancer or for head and neck cancer. Of them, 207 patients required postoperative intensive care for more than 48 h. Of those 207 patients, one patient had hypernatremia (serum sodium concentration of 147 mmol/L) and 22 patients had hyponatremia (average sodium concentration of 132.1 mmol/L) at the time of admission to the ICU. There were five patients with enteral feeding during the study period. The remaining 179 patients were included in this study. As postoperative maintenance fluid, Na 35 fluid was used in 87 patients and Na 140 fluid was used in 92 patients. There were no missing values for this study. Table 2 shows a univariate comparison of the demographics of patients for whom Na 35 fluid and Na 140 fluid were used as postoperative maintenance fluid. There was no Postoperative transfusion, postoperative infusion, and urine output during the study period
Patient demographics
Information on postoperative transfusion, fluid infusion, and urine output during the study period (from ICU admission to 6 a.m. on POD 2) is shown in Table 3 . The study period was not significantly different between the two groups (p = 0.34). The amounts of red blood cell transfusion (p = 0.12) and albumin transfusion (p = 0.24) were not significantly different between the two cohorts. During the study period, the mean volume of fluid received from ICU admission to POD 2 was 3291 mL in the Na 140 cohort, which was not significantly different from the mean volume of 3337 mL in the Na 35 cohort (p = 0.68). The mean volume of Ringer's solution used to correct hypovolemia in the Na 35 cohort was 437 mL. The mean amount of saline infusion for drug delivery was 589 mL in the Na35 cohort, which was not significantly different from the mean amount of 505 mL in the Na 140 cohort. No patients were administered sodium concentrate to correct hyponatremia.
Patients in the Na 140 cohort received a total of 450 mmol of sodium on average, which was significantly larger than that of 243 mmol in the Na 35 group (p < 0.001). Patients in the Na 140 group received a smaller amount of potassium (p < 0.001). Urine output during the study period was not significantly different between the two cohorts (2491 vs 2294 mL on average, p = 0.18). Figure 2 shows a comparison of postoperative serum sodium concentrations. The postoperative sodium concentration was significantly different between the two cohorts (p = 0.0003). The average serum sodium concentration at ICU admission in the Na 35 group was 139.2 mmol/L, which was not significantly different from the average concentration of 138.9 mmol/L in the Na 140 group (post hoc test; p = 0.36). On POD 1 and POD 2, the serum sodium concentrations in the Na 35 group were significantly lower than those in the Na 140 group (post hoc test; mean sodium concentration on POD 1: 136.8 vs 138.0 mmol/L, p < 0.001; on POD 2: 134.7 vs 137.9 mmol/L, p < 0.001). Urine output during study period (mL) 2491 ± 1156 2294 ± 719 0.18 
Postoperative sodium concentration
Incidences of hyponatremia and hypernatremia
The incidences of hyponatremia and hypernatremia are shown in Fig. 3 hoc test, serum glucose concentrations in the Na 140 group were significantly lower than those in the Na 35 group on POD 1 and POD 2. There was no hypoglycemia (defined as <40 mg/dL) in either group.
Postoperative potassium and glucose concentrations
Postoperative outcomes
There was one non-survivor in each of the Na 35 and Na 140 cohorts ( Table 2 ). The number of ICU-free survival days at POD 28 was not significantly different between the two cohorts (24.3 vs 23.8, p = 0.34).
Discussion
Key findings
In this retrospective before/after observational study, we found that the use of postoperative maintenance fluid with 140 mmol/L of sodium was associated with a lower incidence of hyponatremia than when maintenance fluid with 35 mmol/L of sodium was used. There was no significant difference in the incidences of hypernatremia between the two groups. We also found that there was no significant difference between serum potassium concentrations with Na 35 and Na 140 fluid administration. Since there is little information on the impact of postoperative maintenance fluid therapy on the incidence of hyponatremia in postoperative adult patients, our study is novel and relevant.
Comparison with prior studies
Hyponatremia is one of the common complications in postoperative patients [12] . The incidences of hyponatremia (defined as serum sodium concentration <135 mmol/L) were reported to be 24.9% in patients who underwent head and neck surgery [13] , 27.9% in patients who underwent orthopedic surgery [14] , and 59% in patients who underwent cardiac surgery [15] . Hyponatremia was shown to be an independent risk factor of poor outcomes in acutely ill patients [9] , and it may contribute to the occurrence of hyponatremic encephalopathy, especially in pediatric patients [10] . It is difficult to treat hyponatremia in acutely ill patients [3, 16] . Therefore, hyponatremia should be avoided in acutely ill patients including postoperative patients.
In normal conditions, humans have the ability to regulate serum sodium concentration despite differences in the environment and fluid or electrolyte intake [17] . This homeostasis of sodium concentration is regulated through the actions of arginine vasopressin (AVP), the renin-angiotensin-aldosterone system, and natriuretic peptides [3] . However, patients after invasive surgery may have states associated with an excess of AVP induced by various conditions including hypotension, pain, hypoxemia, and inflammation. This excess AVP impairs excretion of free water and may aggravate hyponatremia [3, 18, 19] . Since postoperative patients have a restrictedoral intake, sodium concentration in postoperative intraoperative infusion fluid would contribute to the incidence of postoperative hyponatremia.
Although most previous studies were conducted in pediatric patients, there have been some interventional studies to assess the safety and efficacy of isotonic fluids compared with sodium-poor fluids for the prevention of hyponatremia in an acute care setting [2, [6] [7] [8] . These studies showed that sodium-poor fluids were associated with increased risk of the development of hyponatremia. Nonetheless, sodium-poor fluids continue to be recommended as maintenance fluids in acutely ill patients [4, 5] , being based on theoretical calculations before the syndrome of inappropriate antidiuresis was recognized [3] . A lack of evidence regarding this issue in adult patients may be one of the reasons for such a recommendation.
Limitations
This study has some limitations. First, this was an observational study in nature, which may be influenced by time-related differences regarding preoperative care, operation, anesthesia, and postoperative management. Accordingly, this study is a hypothesis-generating study, not a conclusive study. Further interventional study should be conducted to refute or confirm our findings in postoperative critically ill adult patients.
Second, this was a small single-center study with weak generalizability. Thus, our findings should be validated in other study sites.
Third, we included patients who had undergone an elective operation for esophageal cancer or for head and neck cancer. Our findings might not be applicable in patients receiving other types of surgery. In this regard, a future study should be conducted in a different postoperative cohort.
Fourth, there was no information on the secretion of sodium in urine. In a future prospective study, sodium concentration in urine should be measured.
Finally, this study was conducted to assess the association of maintenance fluid with incidence of hyponatremia. Therefore, this study did not have enough power to assess other clinical outcomes. A large well-powered study should be conducted to compare the risks and benefits of hypotonic fluid and isotonic fluid.
Conclusion
In this retrospective before/after observational study, the use of postoperative maintenance fluid with 35 mmol/L of sodium was significantly associated with an increase in the incidence of hyponatremia compared with that using isotonic fluid with 140 mmol/L of sodium. Further study is necessary to refute or confirm this finding.
